Zelluna ASA [ZLNA]: Share capital increase registered

27 Mar 2025 10:21 CET

Oslo, Norway, 27 March, 2025

Reference is made to the stock exchange notice published on 26 March 2025
regarding the resolution of the board of directors of Zelluna ASA (the
"Company") to carry out a share capital increase of NOK 0.70 through the
issuance of seven (7) new shares, each with a par value of NOK 0.10.

The share capital increase has today been registered with the Norwegian Register
of Business Enterprises. After the share capital increase, the new share capital
of the Company is NOK 20,227,066, divided into 202,270,660 shares.

The share capital increase was carried out in order to achieve a desirable ratio
for the contemplated reverse share split.

A separate notice with key information regarding the reverse share split will be
published shortly.

For further information, please contact:

Hans Vassgård Eid, CFO, Zelluna ASA
Email: hans.eid@zelluna.com (mailto:[%20hans.eid@zelluna.com])
Phone: +47 482 48632

About Zelluna ASA
Zelluna's mission is to deliver transformative treatments with the capacity to
cure advanced solid cancers, in a safe and cost-efficient manner, to patients on
a global scale. The Company aims to do this by combining the most powerful
elements of the immune system through pioneering the development of "off the
shelf" T cell receptor (TCR) guided natural killer (NK) cell therapies (TCR-NK).
The TCR-NK platform offers a unique mechanism of action with broad cancer
detection capability to overcome the diversity of tumours and will be used "off
the shelf" to overcome scaling limitations of current cell therapies. The lead
program is a world's first MAGE-A4 targeting "off the shelf" TCR-NK for the
treatment of various solid cancers; a pipeline of earlier products follows. The
Company is led by a management team of biotech entrepreneurs with deep
experience in discovery through to clinical development of TCR and cell-based
therapies including marketed products.

More information:
Access the news on Oslo Bors NewsWeb site